Lianyungang, China

Xuehong Dong

This inventor holds 2 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignee: Jiangsu Kanion Pharmaceutical Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xuehong Dong. Retrieved from https://idiyas.com/inventor/xuehong-dong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Xuehong Dong: Innovator in Biotechnology

Introduction: Xuehong Dong is a prominent inventor based in Lianyungang, China. She is currently associated with Jiangsu Kanion Pharmaceutical Co., Ltd. Despite having no granted patents to her name, her contributions to the field of biotechnology are noteworthy.

Latest Patent Applications: Xuehong Dong has been involved in several significant patent applications. One of her latest applications is for a recombinant Newcastle disease virus and a preparation method therefor, along with a recombinant plasmid and its use. This recombinant Newcastle disease virus is developed by replacing an F protein of a Newcastle disease virus lasota with an F protein encoded by a specific DNA sequence. The virus is designed to be safe and effective in inhibiting tumor cells and promoting tumor cell apoptosis. Another application focuses on a recombinant Newcastle disease virus obtained by replacing the F protein of a Newcastle disease virus lasota with that of a virulent strain. This chimeric virus demonstrates good safety and efficacy in treating tumors by inhibiting tumor cells and promoting apoptosis.

Conclusion: Xuehong Dong's innovative work in biotechnology, particularly in the development of recombinant Newcastle disease viruses, showcases her commitment to advancing medical science. Her research holds promise for effective cancer treatments and highlights her potential as a leading inventor in her field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…